Group | Non-Aboriginal (n = 438) | Aboriginal (n = 84) | ||||
---|---|---|---|---|---|---|
n | % | (95% CI) | n | % | (95% CI) | |
Risk factors | ||||||
Chemotherapy or steroid use | 14 | 3.2 | (1.8–5.3) | 4 | 4.8 | (1.3–11.7) |
Preterm delivery | 39 | 9.6 | (6.9–12.9) | 11 | 13.9 | (7.2–23.6) |
Any risk factora | 51 | 12.5 | (9.5–16.1) | 13 | 16.5 | (9.1–26.5) |
Comorbidities | ||||||
Congenital abnormality | 29 | 11.2 | (7.6–15.7) | 2 | 4.3 | (0.5–14.8) |
Chronic respiratory disease | 25 | 5.7 | (3.7–8.3) | 7 | 8.3 | (3.4–16.4) |
Cardiovascular disease | 11 | 2.5 | (1.3–4.5) | 3 | 3.6 | (0.7–10.1) |
Disease of nervous system | 10 | 3.9 | (1.9–7.0) | 2 | 4.4 | (0.5–15.2) |
Malignancy | 8 | 1.9 | (0.8–3.7) | 1 | 1.3 | (0.0–6.9) |
Disease of digestive systemb | 5 | 1.9 | (0.6–4.5) | 1 | 2.2 | (0.1–11.8) |
Asplenia | 2 | 0.8 | (0.1–2.8) | 0 | 0 | (0.0–7.7) |
Chronic renal failure | 1 | 0.2 | (0.0–1.3) | 1 | 1.3 | (0.0–6.9) |
Hypertension | 1 | 0.4 | (0.0–2.2) | 1 | 2.3 | (0.1–12.0) |
Anycomorbiditiesa | 61 | 23.2 | (18.3–28.8) | 13 | 26.5 | (15.0–41.1) |
Any risk factors or comorbiditiesa | 92 | 33.7 | (28.1–39.6) | 21 | 38.9 | (25.9–53.1) |